News Room

Wednesday, June 13, 2007

Vioxx Attorney

Securing the expert counsel of a Vioxx attorney is crucial in protecting your interests in a legal claim against Merck, the makers of this once-popular prescription pain medication. In 1999 the FDA approved Vioxx, a non-steroidal anti-inflammatory drug (NSAID), for the treatment of arthritis and other chronic pain conditions. Merck aggressively promoted Vioxx as a safer and more effective means of relieving pain in comparison to over the counter medication such as ibuprofen and naproxen . Vioxx was known for being gentler than traditional NSAIDS, while providing powerful pain relief.

In 2004, Vioxx was pulled off the market after a study showed that using Vioxx for 18 months or longer doubled the risk of serious cardiovascular problems such as heart attacks and strokes. Results also showed that Vioxx patients suffered from seizures and serious liver and kidney problems. At the time of the Vioxx recall, approximately 20 million people had used Vioxx to treat various pain conditions.

There have been over 7,000 lawsuits filed against the makers of Vioxx on behalf of people who have been severely injured by the drug. A qualified Vioxx attorney can provide you with the specific regulations regarding your suit as well as provide a knowledgeable background of the current findings. The advantage of obtaining the counsel of a Vioxx attorney is the experience that they have in dealing with numerous similar Vioxx injury cases. These knowledgeable attorneys can help in discovering what the appropriate path for litigation is for those who have suffered injury and other losses.

If Vioxx has affected you or a loved one, it is in your best interest to contact an experienced Vioxx attorney who can inform you of your rights and options. A Vioxx attorney is prepared to help you take the appropriate steps for your legal and personal well being. Please contact us to confer with a Vioxx attorney in your area for a free consultation regarding your case.

Technorati tags:

No comments: